Eu Ivdd Eu Ivd General On The Market 🇨🇳 China

CREATINE KINASE - TOTAL

Devices (same UDI-DI)
1
Certificates
0
Countries
6
Notified Bodies
0

Basic Information

Primary DI
06975225461599
Basic UDI-DI Code
B-06975225461599
Reference
DTSH040105
Device Types
None provided
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market

Additional Description

This kit is intended for in vitro quantitative detection of creatine kinase (CK) in human serum. Increased activity common to all types of progressive muscular atrophy, Duchenne muscular dystrophy, etc. Creatine kinase increased: mainly used for the diagnosis of myocardial infarction and various types of progressive muscular atrophy, skeletal muscle injury, muscular dystrophy, acute myocarditis, cerebrovascular accident, meningitis, thyroid dysfunction, strenuous exercise, the use of chlorpromazine, penicillin and other drugs. Determination of creatine kinase activity has an important value in the diagnosis of these diseases.

CND Nomenclature Codes

Code Description
W01010113 CREATINE KINASE - TOTAL

Available In Countries

🇧🇪 Belgium 🇩🇪 Germany 🇫🇷 France 🇮🇹 Italy 🇳🇱 Netherlands 🇸🇪 Sweden

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all